Skip to main content

CON-TGO91-309 - Novartis Pharmaceuticals Australia Pty Ltd

Product names
  • AUST R 160177 ONBREZ BREEZHALER indacaterol maleate 300 microgram hard capsule for inhalation - Batch BRW91
Decision Date
Duration
The duration of consent is for the batches specified above.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site